Protein C Antigen Levels in Major Abdominal Surgery: Relationships to Deep Vein Thrombosis, Malignancy and Treatment with Stanozolol

Summary

Activated protein C is a potent inhibitor of coagulation, and familial protein C deficiency has been associated with recurrent venous thrombosis. We have investigated protein C antigen levels in patients undergoing major elective abdominal surgery, to determine their relationships to postoperative deep vein thrombosis (DVT), malignancy, and preoperative treatment with intramuscular or oral stanozolol. Preoperative and postoperative protein C levels were not significantly different in patients with and without DVT (detected by ¹²⁵I-fibrinogen leg scans), nor in patients with and without malignancy. In a placebo group (n = 26), a significant fall in protein C was maximal on the first postoperative day and persisted for 7 days. In a group given intramuscular stanozolol, 50 mg on the preoperative day (n = 23) stanozolol shortened the duration of the postoperative fall in protein C, but did not prevent DVT. In a group given oral stanozolol, 10 mg/day for 2 weeks before and 1 week after operation (n = 11), stanozolol significantly increased protein C levels prior to surgery, hence maintaining protein C at pretreatment levels after surgery. The effect of this regimen on the incidence of DVT is under study.

Keywords

Protein C - Deep vein thrombosis - Surgery - Malignancy - Anabolic steroids

• References

• 1 Esmon CT. Protein C: biochemistry, physiology and clinical implications. Blood 1983; 62: 1155-1158
• 2 Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373
• 3 Bertina RM, Broekmans AW, van der Linden IK, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemostas 1982; 48: 1-5
• 4 Broekmans AW, Veltkamp JJ, Bertina RM. Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families. N Engl J Med 1983; 309: 340-344
• 5 Griffin JH, Mosher DF, Zimmerman TS, Kleiss AJ. Protein C, an antithrombotic protein, is reduced in hospitalised patients with intravascular coagulation. Blood 1982; 60: 261-264
• 6 Mannucci PM, Vigano S. Deficiencies of protein C, aninhibitor of. blood coagulation. Lancet 1982; 2: 463-467
• 7 Kluft C, Bertina RM, Preston FE, Malia RG, Blarney SL, Lowe GDO, Forbes CD. Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozolol. Thromb Res 1984; 33: 297-304
• 8 Blarney SL, McArdle BM, Burns P, Carter DC, Lowe GDO, Forbes CD. A double-blind trial of intramuscular stanozolol in the prevention of postoperative deep vein thrombosis following elective abdominal surgery. Thromb Haemostas 1984; 51: 71-74
• 9 Small M, MacLean JA, McArdle BM, Bertina RM, Lowe GDO, Forbes CD. Haemostatic effects of stanozolol in elderly medical patients. Thromb Res 1984; 35: 353-8
• 10 Lowe GDO, Osborne DH, McArdle BM, Smith A, Carter DC, Forbes CD, McLaren D, Prentice CRM. Prediction and selective prophylaxis of venous thrombosis in elective gastrointestinal surgery. Lancet 1982; 1: 409-412
• 11 Sue-Ling HM, Davies JA, McMahon MJ, Johnston D, Philips PR, Anderson JA, Bertina RM, Verheijen JH, Kluft C. Indicators of depressed fibrinolytic activity in prediction ofpost-operative deep vein thrombosis. Hemostasis 1984; 14: 97
• 12 O’Connor NTJ, Broekmans AW, Bertina RM. Protein C values in coronary artery disease. Br Med J 1984; 289: 1192